Alex Amos > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices

Kirkland & Ellis International LLP
30 ST MARY AXE
LONDON
EC3A 8AF
England
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Alex Amos

+44 20 7469 2039 [email protected]
Work Department
Investment Funds
Position
Alex advises a wide range of asset managers and investors on alternative funds. His particular focus is on credit strategies. This ranges from primary funds, SMAs, joint ventures, pledge funds, co-investment vehicles and other alternatives to the traditional widely held blind pool fund model.
Career
2024 to present Kirkland & Ellis International LLP; 2012-2023 Macfarlanes; 2010-2012 Goldman Sachs Asset Management
Education
University of Bristol (B.A., Modern Languages)
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Dispute resolution > Tax litigation and investigations
- Investment fund formation and management > Fund finance
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Industry focus > TMT
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Private client > Charities and not-for-profit
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium